Related Experiment Video
Updated: Jun 13, 2026

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
[Inflammatory cytokines]
Hideto Ishii1, Masayuki Yoshida
1Life Science and Bioethics Research Center, Tokyo Medical and Dental University.
Abstract:
Diabetic macroangiopathy is severe complication for diabetes mellitus, and inflammatory cytokines induces various reactions for the formation of atherosclerosis in diabetes. In addition, recent reports indicate the accumulation of macrophages in the adipose tissue occurs in diabetes and these macrophages secret an inflammatory cytokines. It is also known macrophages produce most of circulating TNF-alpha. Accordingly, inflammatory cytokines, produced in adipose tissue, influence systemic inflammation possibly. Leukocyte-endothelial interactions are critical in the progression of inflammation and atherosclerosis. Recruitment of leukocytes to the sites of inflammation or atherosclerosis prone vasculature involves multistep complex cascades of adhesion events, which inflammatory cytokines induce. Inflammatory cytokines are not the only factor in diabetic macroangiopathy, however, it is certain that inflammation plays important role in diabetes and diabetic vascular complication.
Insights
Diabetic macroangiopathy involves inflammation, where cytokines and macrophages in adipose tissue promote atherosclerosis. This systemic inflammation contributes to diabetic vascular complications.
Area of Science:
- Biomedical science
- Immunology
- Endocrinology
Context:
- Diabetic macroangiopathy is a severe complication of diabetes mellitus.
- Inflammatory cytokines play a key role in atherosclerosis development in diabetic patients.
- Macrophages accumulate in adipose tissue during diabetes, secreting inflammatory cytokines like TNF-alpha.
Purpose:
- To elucidate the role of inflammatory cytokines and macrophage activity in diabetic macroangiopathy.
- To understand the link between adipose tissue inflammation and systemic inflammation in diabetes.
- To explore the mechanisms of leukocyte-endothelial interactions in diabetic vascular complications.
Summary:
- Inflammatory cytokines, produced by macrophages in adipose tissue, contribute to systemic inflammation in diabetes.
- These cytokines induce leukocyte-endothelial interactions, crucial for atherosclerosis progression.
- While not the sole factor, inflammation is central to diabetic macroangiopathy and vascular issues.
Impact:
- Highlights the critical role of inflammation in diabetic vascular complications.
- Provides insights into the mechanisms underlying atherosclerosis in diabetes.
- Suggests potential therapeutic targets for managing diabetic macroangiopathy.
Related Concept Videos
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Acute Inflammation III: Local and Systemic Effects
Inflammatory Response I: Vascular and Cellular
Inflammatory Bowel Disease II: Ulcerative Colitis
Acute Inflammation I: Inflammatory Response
Acute Inflammation II: Cellular Phase

